{"id":"W4283709628","doi":"10.1136/annrheumdis-2022-eular.1268","title":"POS0643 SUSTAINABILITY OF RESPONSE BETWEEN UPADACITINIB AND ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS THROUGH 3 YEARS FROM THE SELECT-COMPARE TRIAL","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institutes of Health; Odense Universitetshospital; Amgen; National Institute of Allergy and Infectious Diseases; Bristol-Myers Squibb","keywords":"Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Discontinuation; Placebo; Methotrexate; Post-hoc analysis; Clinical trial; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001152481,0.0001801223,0.000656892,0.00007237917,0.0001570101,0.00002008653,0.000437855,0.00003439693,0.00006665762],"category_scores_gemma":[0.004511274,0.0001118261,0.0001477508,0.0005332286,0.0005137863,0.0001021572,0.000425431,0.0002422727,8.66125e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007621202,"about_ca_system_score_gemma":0.004306021,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003165549,"about_ca_topic_score_gemma":0.00006681102,"domain_scores_codex":[0.9961122,0.001189626,0.0008100829,0.0003338994,0.00119454,0.0003596694],"domain_scores_gemma":[0.9953695,0.002877386,0.0004010063,0.0009563944,0.0002872878,0.0001084437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6405846,0.002684899,0.3148654,0.000562585,0.000898725,0.00003389402,0.01115097,0.0004091549,0.000002780288,0.0001362732,0.007782663,0.02088808],"study_design_scores_gemma":[0.1263106,0.00150682,0.8659473,0.0009107861,0.00006251008,0.000003530433,0.00242821,0.00009826428,0.0000734366,0.002209414,0.0003098577,0.0001392983],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930444,0.001562505,0.000001667994,0.002019879,0.00004009628,0.0019144,0.001369242,0.00001653066,0.00003128118],"genre_scores_gemma":[0.9994081,0.0001785072,0.00002265443,0.0001167633,0.00001546399,0.00009682074,0.0001087275,0.00002404068,0.00002895907],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5510819,"threshold_uncertainty_score":0.7638696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02712574030222329,"score_gpt":0.3076212486889632,"score_spread":0.2804955083867399,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}